The US Food and Drug Administration granted accelerated approval Friday for the Alzheimer's disease drug lecanemab, one of the first experimental dementia drugs to appear to slow the progression of cognitive decline.
from CNN.com - RSS Channel - App International Edition https://ift.tt/xEitwcs
via IFTTT
Friday, 6 January 2023
Subscribe to:
Post Comments (Atom)
Hello, my name is Jack Sparrow. I'm a 50 year old self-employed Pirate from the Caribbean.
No comments:
Post a Comment